TP-1454 is an investigational oral pyruvate kinase (PKM2) activator. This activation is thought to starve the cells of important molecular building blocks, inhibiting tumor cell production, and enhancing anti-tumor response.
#cancer therapy #trimer #PKM2 activator #tumor cell #anti-tumor
Keywords: 3D, Patient Education, Professional Education, Oncology, Mechanism of Action (MOA), Health & Wellness
© Jackie Heda